Boardroom Alpha
8-K primary document
KLTR · Current Report (Form 8-K) · Filed December 8, 2025

Kaltura Inc8-K exhibit

paoappointmentletter-clair.htm
Document
image.jpg

December 8, 2025


To:
Ms. Claire Rotshten

Dear Claire,

Re: Appointment as Interim Principal Accounting Officer (“PAO”)


We are pleased to appoint and designate you as an interim Principal Accounting Officer (“PAO”) of Kaltura, Inc. (including its subsidiaries) (the “Company”) effective as of December 6, 2025 (“Effective Date”) and hereby ratify your appointment as of such date. This letter outlines the principal terms, duties, and responsibilities of your role. It serves as an addendum to your employment agreement and forms an integral part thereof.
1.    Position and Reporting
You will serve as the Company’s interim PAO and will report to the Chief Executive Officer (“CEO”), with regular reporting duties to the Board of Directors and its Audit Committee.
2.    Scope of Responsibilities
Your responsibilities shall include, without limitation:
2.1.    Overseeing the Company’s accounting policies, internal controls over financial reporting, global consolidation, tax reporting, and financial close processes.
2.2.    Ensuring compliance with U.S. GAAP and SEC reporting requirements, including preparation and review of Forms 10‑K, 10‑Q, and 8‑K (as applicable).
2.3.    Managing external auditors, SOX compliance, and internal audit processes.
2.4.    Collaborating with the Principal Financial Officer (“PFO”) to support budgeting, forecasting, and financial analysis.
2.5.    Supporting the Company’s risk‑management framework and presenting accounting matters to the Audit Committee.
2.6.    Any other responsibilities and authorizations as set forth under the applicable laws.
3.    Successor to CFO Duties
Along with the Principal Financial Officer, you will jointly assume and perform the duties typically assigned to the Chief Financial Officer (“CFO”), until such time as the Company appoints a permanent CFO or determines otherwise.
4.    Authority
You will have full authority to implement accounting policies, oversee the Company’s financial statements, and access financial systems and records necessary to perform your duties.
5.    Term
Your appointment is intended to be of a temporary nature until the appointment and designation of a permanent CFO for the Company. Your appointment shall become effective on the Effective Date and shall continue until modified or terminated by the Company pursuant to applicable agreements and policies.


1



6.    Acceptance
Please sign below to acknowledge your acceptance of this appointment.


Sincerely yours,


Sigal Srur
Chief Human Resources Officer


Accepted and agreed,

By:

Name:
Claire Rotshten
Date:
December 8, 2025



2
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer